Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3369-3377

  Mittendorf, Elizabeth A ^a   Sahin, Aysegul A ^a   Tucker, Susan L ^a   Meric Bernstam, Funda ^a   Yi, Min ^a   Nayeemuddin, Khazi M ^a   Babiera, Gildy V ^a   Ross, Merrick I ^a   Feig, Barry W ^a   Kuerer, Henry M ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPHOVASCULAR INVASION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58149277503     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0153-2     Document Type: Article

References (39)

1. RE Mansel L Fallowfield M Kissin 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 599 609
2. AD Purushotham S Upponi MB Klevesath 2005 Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial J Clin Oncol 23 4312 21
3. U Veronesi G Paganelli G Viale 2003 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546 53
4. AE Giuliano PS Dale RR Turner 1995 Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 394 9 discussion 399-401
5. L Liberman 2000 Pathologic analysis of sentinel lymph nodes in breast carcinoma Cancer 88 971 7
6. JC Boughey I Bedrosian F Meric-Bernstam 2006 Comparative analysis of sentinel lymph node operation in male and female breast cancer patients J Am Coll Surg 203 475 80
7. C Cox L White N Allred 2006 Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy Ann Surg Oncol 13 708 11
8. Greene FL, Page DL, Fleming ID, eds. (2002) Breast. In: AJCC Cancer Staging Manual, 6th edition. New York: Springer, pp 223-40
9. DN Krag TB Julian SP Harlow 2004 NSABP-32: phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial Ann Surg Oncol 11 208S 10S
10. DL Weaver DN Krag T Ashikaga 2000 Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study Cancer 88 1099 107
11. American College of Surgeons Oncology Group (ASOCOG). Available at: www.acosog.org/. Accessed September 5, 2008
12. TM Breslin L Cohen A Sahin 2000 Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer J Clin Oncol 18 3480 6
13. LA Lambert GD Ayers RF Hwang 2006 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy Ann Surg Oncol 13 310 20
14. MA Yared LP Middleton TL Smith 2002 Recommendations for sentinel lymph node processing in breast cancer Am J Surg Pathol 26 377 82
15. ER Fisher S Swamidoss CH Lee 1978 Detection and significance of occult axillary node metastases in patients with invasive breast cancer Cancer 42 2025 31
16. AG Huvos RV Hutter JW Berg 1971 Significance of axillary macrometastases and micrometastases in mammary cancer Ann Surg 173 44 6
17. JW Pickren 1961 Significance of occult metastases. A study of breast cancer Cancer 14 1266 71
18. MC Cummings MD Walsh BG Hohn 2002 Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis Am J Surg Pathol 26 1286 95
19. IA Nasser AK Lee S Bosari 1993 Occult axillary lymph node metastases in "node-negative" breast carcinoma Hum Pathol 24 950 7
20. LK Tan D Giri AJ Hummer 2008 Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up J Clin Oncol 26 1803 9
21. P Querzoli M Pedriali R Rinaldi 2006 Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients Clin Cancer Res 12 6696 701
22. N Hansen B Grube C Ye 2007 The impact of micrometastases in the sentinel nodes of patients with invasive breast cancer Breast Cancer Res Treat 106 Suppl 1 S15
23. CE Cox JV Kiluk AI Riker 2008 Significance of sentinel lymph node micrometastases in human breast cancer J Am Coll Surg 206 261 8
24. IJ Bleiweiss CS Nagi S Jaffer 2006 Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma J Clin Oncol 24 2013 8
25. BA Carter RA Jensen JF Simpson 2000 Benign transport of breast epithelium into axillary lymph nodes after biopsy Am J Clin Pathol 113 259 65
26. NM Diaz CE Cox M Ebert 2004 Benign mechanical transport of breast epithelial cells to sentinel lymph nodes Am J Surg Pathol 28 1641 5
27. AK Lee M Loda G Mackarem 1997 Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO): clinicopathologic features and outcome Cancer 79 761 71
28. SP Leitner AS Swern D Weinberger 1995 Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0) Cancer 76 2266 74
29. GB Mann ER Port C Rizza 1999 Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma Ann Surg Oncol 6 591 8
30. CA Quiet DJ Ferguson RR Weichselbaum 1995 Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up J Clin Oncol 13 1144 51
31. J Shen KK Hunt NQ Mirza 2005 Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence Cancer 104 479 90
32. AK Rivers KA Griffith KK Hunt 2006 Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node Ann Surg Oncol 13 36 44
33. RF Hwang S Krishnamurthy KK Hunt 2003 Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 10 248 54
34. KJ Van Zee DM Manasseh JL Bevilacqua 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 51
35. JL Bevilacqua MW Kattan JV Fey 2007 Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol 25 3670 9
36. G Cserni S Bianchi V Vezzosi 2006 The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma J Clin Pathol 59 518 22
37. EA Mittendorf KK Hunt 2007 Significance and management of micrometastases in patients with breast cancer Expert Rev Anticancer Ther 7 1451 61
38. G Viale E Maiorano G Pruneri 2005 Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy Ann Surg 241 319 25
39. EO Hanrahan V Valero AM Gonzalez-Angulo 2006 Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1;T1a,bN0M0): a review of the literature J Clin Oncol 24 2113 22